IN RE: MODAFINIL ANTITRUST LITIGATION

Reset A A Font size: Print

United States Court of Appeals, Third Circuit.

IN RE: MODAFINIL ANTITRUST LITIGATION Mylan Laboratories, Inc.; Mylan Pharmaceuticals Inc.; Ranbaxy Laboratories, Ltd; Ranbaxy Pharmaceuticals, Inc., Appellants

No. 15-3475

Decided: September 29, 2016

Before: SMITH, JORDAN, and RENDELL, Circuit Judges

ORDER AMENDING OPINION

The opinion filed September 13, 2016 is amended solely as to the listing of Paul B. Hewitt, Esq. and Catherine Creely, Esq. on the opinion and not as to the substance of the opinion itself. Mr. Hewitt and Ms. Creely should have been listed as members of Akin Gump Strauss Hauer & Feld in Washington, DC. Mr. Hewitt was omitted from the listing of counsel and Ms. Creely was erroneously listed as a member of Cohn & Marks in Washington, DC. The opinion is amended as follows:

Paul B. Hewitt

C. Fairley Spillman

Catherine E. Creely

Akin Gump Strauss Hauer & Feld

1333 New Hampshire Avenue, N.W.

Suite 400

Washington, DC 20036

For the Court,

Marcia M. Waldron, Clerk